Although CTGF exists in healthy kidneys as a form of low level, the level is dramatically elevated in a variety of renal illnesses, and it has a substantial impact on the progression of progressive kidney illness (Toda et al., 2018)
Real-world application still requires further scrutiny, time, and frank conversations with clinicians
9 Banihani S, Agarwal A, Sharma R & Bayachou M
In all, both ouabain and marinobufagenin have been shown to curtail cytokine production, and since this occurs even at low concentrations that do not inhibit Na,K-ATPase, it can be assumed that the observed effects are mediated by the activation of signaling cascades
10.2147/CLEP.S37505 [DOI] [PMC free article] [PubMed] [Google Scholar] Inoue H., Jiang X